Side-by-side comparison of AI visibility scores, market position, and capabilities
Atlanta B2B payments (NYSE: CPAY, rebranded from FLEETCOR) at $3.975B FY2024 revenue; fleet cards, AP automation, Cambridge cross-border payments, Q4 organic growth +12%, adjusted net income $1.4B competing with WEX.
Corpay, Inc. is an Atlanta, Georgia-based B2B payments technology company — publicly traded on the New York Stock Exchange (NYSE: CPAY) as an S&P 500 Financials component (rebranded from FLEETCOR Technologies to Corpay in 2024) — providing corporate fleet card payments, virtual card accounts payable automation, cross-border currency payments, and lodging payment management to corporate, government, and commercial vehicle fleet customers in 100+ countries through approximately 10,000 employees. In fiscal year 2024, Corpay reported record Q4 revenues of $1.034 billion (+10% year-over-year) with organic revenue growth of 12% and adjusted EPS growth of 21%, and full-year revenues of $3.975 billion with adjusted net income of $1.4 billion. The company is organized across three segments: Vehicle Payments (fleet fuel cards, tolling solutions, and vehicle-related expense management — the original FLEETCOR fleet card business), Corporate Payments (virtual cards, AP automation, and cross-border B2B payments through the Cambridge Global Payments platform), and Lodging Payments (corporate lodging payment solutions for trucking, construction, and hospitality workforce programs). CEO Ron Clarke has led Corpay's growth through a decade of acquisitions, rebranding the company as Corpay in 2024 to reflect the expanding portfolio beyond fleet cards into the broader B2B payments market.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.